Blog Posts

Oregon House to Vote Today on 340B Contract Pharmacy Bill

Oregon state lawmakers pulled a bill to bar drugmaker 340B contract pharmacy restrictions shortly after a similar Utah bill died in committee.
The Oregon state house is scheduled to vote today on a bill that would prohibit drugmaker 340B contract pharmacy restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

DSH Hospitals Are Using 340B in ‘Margin-Motivated Ways,’ Says Research Review

A recent Milbank Quarterly research review suggested DSH hospitals participate in 340B in "margin-motivated ways."
The highest-quality evidence from published 340B research indicates nonprofit, disproportionate share hospitals may be using the 340B program in margin-motivated [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: Key Takeaways from Senate Group of Six Draft 340B Bill (Part 1)

Ted Slafsky, publisher and CEO of 340B Report, writes the second part of his two-part column on the Senate "group of six" 340B discussion draft.
After reviewing comments from over 250 stakeholders, meeting with various interest groups and holding regular staff meetings, the U.S. Senate [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B ESP New Data Request Raises Concerns About Overreach

Courtney McFarland, partner at AAFCPAs, said 340B ESP was asking for types of data that she had not seen the vendor previously request.
The drugmaker vendor 340B ESP’s recent requests for additional claims data from some 340B hospitals has raised concerns from 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

South Dakota Legislature Clears New PBM 340B Bill; Missouri Debates 340B Bills; Kentucky Contract Pharmacy Bill Advances

The South Dakota House and Senate passed a PBM 340B bill that expands on a 2019 state law.
Following the recent passage in the state house, the South Dakota Senate approved a bill earlier this week to bar [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Part 1 of 2: Understanding the Top Five Challenges Facing Health Center Pharmacies Today

Holly Russo headshot

SPONSORED CONTENT

Part 1 of 2: Managing costs and ensuring favorable contracting

As industry veterans know too well, having an in-house pharmacy can be greatly beneficial for both community health centers (CHCs) and their patients. Not only do they offer patient convenience and a greater level of transparency into medication adherence or prescription abandonment, but they also allow for improved engagement and educational opportunities, the potential for revenue growth, and enhancements to clinical programs that can translate directly into better health outcomes.

However, in-house pharmacies face a growing set of challenges, from managing purchasing and inventory to rising drug costs, drug shortages, unpredictable patient demand, payer contracting, staffing shortages, and regulatory complexities. And, as at least half of the average CHC patient populations is covered by Medicaid,[1] the program’s unwinding of its continuous enrollment provision will mean an additional

Read More »

Soon After Governor Proposes 340B Provider Reporting Legislation, Connecticut Senate Introduces Similar Bill

Connecticut state capitol
Connecticut state senators introduced a bill that would implement annual 340B provider reporting requirements shortly after a health office reporting to the governor proposed similar legislation.
Connecticut state lawmakers yesterday introduced a bill to require annual reporting by 340B providers to the state government on their [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two 340B Site Terminations, One Payback to Manufacturers in Latest Provider Audit Findings

HRSA provider audits
HRSA audits found terminations were required for a 340B provider site and a contract pharmacy and that another provider owed repayments to drugmakers.
Federal auditors determined terminations from the 340B program were required for either a covered entity site or a contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report